368 related articles for article (PubMed ID: 23738593)
41. Stimulant Treatment of Young People in the United States.
Olfson M; King M; Schoenbaum M
J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):520-6. PubMed ID: 26982632
[TBL] [Abstract][Full Text] [Related]
42. Practitioner review: Psychopharmacology in children and adolescents with mental retardation.
Handen BL; Gilchrist R
J Child Psychol Psychiatry; 2006 Sep; 47(9):871-82. PubMed ID: 16930381
[TBL] [Abstract][Full Text] [Related]
43. Psychotropic medicine prescriptions in Italian youths: a multiregional study.
Piovani D; Clavenna A; Cartabia M; Bonati M
Eur Child Adolesc Psychiatry; 2016 Mar; 25(3):235-45. PubMed ID: 26016693
[TBL] [Abstract][Full Text] [Related]
44. Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder.
Jerrell JM; McIntyre RS; Tripathi A
Hum Psychopharmacol; 2011 Oct; 26(7):451-9. PubMed ID: 21898598
[TBL] [Abstract][Full Text] [Related]
45. Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults.
Bliddal M; Rasmussen L; Andersen JH; Jensen PB; Pottegård A; Munk-Olsen T; Kildegaard H; Wesselhoeft R
JAMA Psychiatry; 2023 Feb; 80(2):176-180. PubMed ID: 36515919
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of psychoactive medication in children and adolescents.
Quinn DM
Can J Psychiatry; 1986 Aug; 31(6):575-80. PubMed ID: 2875781
[TBL] [Abstract][Full Text] [Related]
47. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
48. [Use of methylphenidate among children in Iceland 1989-2006].
Zoëga H; Baldursson G; Halldórsson M
Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
[TBL] [Abstract][Full Text] [Related]
49. Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care.
Martin A; Van Hoof T; Stubbe D; Sherwin T; Scahill L
Psychiatr Serv; 2003 Jan; 54(1):72-7. PubMed ID: 12509670
[TBL] [Abstract][Full Text] [Related]
50. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.
Hanley GE; Mintzes B
BMC Pregnancy Childbirth; 2014 Jul; 14():242. PubMed ID: 25048574
[TBL] [Abstract][Full Text] [Related]
51. Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees.
Keefe RJ; Cummings ADL; Smith AE; Greeley CS; Van Horne BS
J Child Adolesc Psychopharmacol; 2023 May; 33(4):149-155. PubMed ID: 37204275
[No Abstract] [Full Text] [Related]
52. Psychotropic Prescriptions During the COVID-19 Pandemic Among U.S. Children and Adolescents Receiving Mental Health Services.
Amill-Rosario A; Lee H; Zhang C; dosReis S
J Child Adolesc Psychopharmacol; 2022 Sep; 32(7):408-414. PubMed ID: 36067121
[No Abstract] [Full Text] [Related]
53. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers.
Zito JM; Safer DJ; Valluri S; Gardner JF; Korelitz JJ; Mattison DR
J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):195-203. PubMed ID: 17489714
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration.
Barry DT; Sofuoglu M; Kerns RD; Wiechers IR; Rosenheck RA
Psychiatry Res; 2015 Jun; 227(2-3):324-32. PubMed ID: 25863822
[TBL] [Abstract][Full Text] [Related]
55. Gender differences in the prevalence and correlates of psychotropic medication use among older adults in Israel.
Blumstein T; Benyamini Y; Shmotkin D; Lerner-Geva L
Isr J Psychiatry Relat Sci; 2014; 51(2):118-25. PubMed ID: 25372561
[TBL] [Abstract][Full Text] [Related]
56. Prescribing changes in anxiolytics and antidepressants in Slovenia.
Svab V; Subelj M; Vidmar G
Psychiatr Danub; 2011 Jun; 23(2):178-82. PubMed ID: 21685857
[TBL] [Abstract][Full Text] [Related]
57. Psychotropic medication history of inpatient adolescents--is there a rationale for benzodiazepine prescription?
Ilomäki R; Ilomäki E; Hakko H; Räsänen P
Addict Behav; 2011; 36(1-2):161-5. PubMed ID: 21035951
[TBL] [Abstract][Full Text] [Related]
58. Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility.
Procyshyn RM; Su J; Elbe D; Liu AY; Panenka WJ; Davidson J; Honer WG; Barr AM
J Clin Psychopharmacol; 2014 Feb; 34(1):17-22. PubMed ID: 24346744
[TBL] [Abstract][Full Text] [Related]
59. Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009.
Zetterqvist J; Asherson P; Halldner L; Långström N; Larsson H
Acta Psychiatr Scand; 2013 Jul; 128(1):70-7. PubMed ID: 22943458
[TBL] [Abstract][Full Text] [Related]
60. Emergency department visits by adults for psychiatric medication adverse events.
Hampton LM; Daubresse M; Chang HY; Alexander GC; Budnitz DS
JAMA Psychiatry; 2014 Sep; 71(9):1006-14. PubMed ID: 25006837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
